glp-1 medications approved for diabetes and weight loss 2025 are marketed to help you lose weight, but one may be better at it than the rest, according to a new meta-analysis from the UGA College of Pharmacy. Tirzepatide, better National Hispanic Medical Association |

Youre stuck choosing between your health and your budgetwhat we call the Quality-Price Gap

Yu H, Song Z, Yu J, Ren B, Dong Y, You Y, Zhang Z, Jia C, Zhao Y, Zhou X, Sun H, Zhang X

We wanted to resolve the lack of consensus with our work. Analyzing de-identified patient data collected from December 2017 through December 2024 across 12 databases managed by the Observational Health Data Sciences and Informatics (OHDSI) network-an international and interdisciplinary collaborative of researchers and observational health databases the researchers followed the health outcomes of adults with type 2 diabetes who had been prescribed semaglutide (227,971), dulaglutide (68,588), exenatide (5,460), empagliflozin (252,356), sitagliptin (100,083) or glipizide (213,515) for the first time

N., Norton, J

Vitamin B12 Has known side effects

It is widely studied for its potential to influence GnRH (Gonadotropin-Releasing Hormone) secretion , making it a key subject in research on fertility, reproductive hormone modulation, and endocrine function